Genmab A/S(DE:GE9)
€467.30-0.40 (-0.09%)
DE:GE9
Genmab A/S earnings date
€467.30
At close:-0.40 (-0.09%)
Genmab A/S (GE9) Q4 2022 Earnings Report
15 Followers
DE:GE9 Q4 2022 EPS Results
- Actual EPS
- EUR 1.13
- Consensus EPS
- EUR 3.06
- Beat/Miss
- Missed by -EUR 1.93
- One Year Ago EPS
- EUR 1.50
DE:GE9 Q4 2022 Revenue Results
- Actual Revenue
- EUR 699.21M
- Expected Revenue
- EUR 618.22M
- Beat/Miss
- Beat by +EUR 80.99M
- YoY Revenue Growth
- +99.58%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 02/22/2023
- Time
- During Market Hours
- Conference Call
- Wednesday, February 22, 2023
DE:GE9 Upcoming Earnings
Genmab A/S's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GE9 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | 1.92- | 0.45 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | 3.175.00 | 5.86 | -14.71% (-0.86) | |
| Aug 06, 2026 | 2026 (Q2) | 3.234.45 | 4.92 | -9.41% (-0.46) | |
| May 07, 2026 | 2026 (Q1) | 1.410.75 | 2.77 | -72.79% (-2.01) | |
| Feb 17, 2026 | 2025 (Q4) | 2.550.45 | 7.72 | -94.12% (-7.27) | |
| Nov 06, 2025 | 2025 (Q3) | 4.415.86 | 2.61 | 124.93% (+3.26) | |
| Aug 07, 2025 | 2025 (Q2) | 3.624.92 | 2.88 | 70.87% (+2.04) | |
| May 08, 2025 | 2025 (Q1) | 2.132.77 | 2.65 | 4.60% (+0.12) | |
| Feb 12, 2025 | 2024 (Q4) | 3.397.72 | 1.27 | 510.04% (+6.46) | |
| Nov 06, 2024 | 2024 (Q3) | 2.802.61 | 4.21 | -38.10% (-1.60) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

